I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Gok Yavuz, Betul
124
results:
Search for persons
X
Format
Online (124)
Mediatypes
E-Books (1)
Articles (Online) (83)
Bookchapter (Online) (2)
OpenAccess-fulltext (38)
Sorted by: Relevance
Sorted by: Year
?
1
Individual ingredients of NP-101 (Thymoquinone formula) inh..:
Maen, Abdelrahim
;
Gok Yavuz, Betul
;
Mohamed, Yehia I.
...
Frontiers in Pharmacology. 15 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
2
The Gut Microbiome as a Biomarker and Therapeutic Target in..:
Gok Yavuz, Betul
;
Datar, Saumil
;
Chamseddine, Shadi
...
Cancers. 15 (2023) 19 - p. 4875 , 2023
Link:
https://doi.org/10.3390/..
?
3
Serum IGF-1 Scores and Clinical Outcomes in the Phase III I..:
Kaseb, Ahmed O
;
Guan, Yinghui
;
Gok Yavuz, Betul
...
Journal of Hepatocellular Carcinoma. 9 (2022) - p. 1065-1079 , 2022
Link:
https://doi.org/10.2147/..
?
4
A Randomized, Double-Blind, Placebo-Controlled, Multicenter..:
Bencheqroun, Hassan
;
Ahmed, Yasir
;
Kocak, Mehmet
...
Pathogens. 11 (2022) 5 - p. 551 , 2022
Link:
https://doi.org/10.3390/..
?
5
Current Landscape and Future Directions of Biomarkers for I..:
Gok Yavuz, Betul
;
Hasanov, Elshad
;
Lee, Sunyoung S
...
Journal of Hepatocellular Carcinoma. 8 (2021) - p. 1195-1207 , 2021
Link:
https://doi.org/10.2147/..
?
6
Omacetaxine added to a standard acute myeloid leukaemia che..:
Hwang, Jonwei
;
Singh, Naina
;
Braniecki, Marylee
...
British Journal of Haematology. 195 (2021) 3 - p. , 2021
Link:
https://doi.org/10.1111/..
?
7
Cancer associated fibroblasts sculpt tumour microenvironmen..:
Gok Yavuz, Betul
;
Gunaydin, Gurcan
;
Gedik, M. Emre
...
Scientific Reports. 9 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1038/..
?
8
The effects of cancer-associated fibroblasts obtained from ..:
Gok Yavuz, Betul
;
Gunaydin, Gurcan
;
Kosemehmetoglu, Kemal
...
The Breast Journal. 24 (2018) 6 - p. 1099-1101 , 2018
Link:
https://doi.org/10.1111/..
?
9
Origin and role of hepatic myofibroblasts in hepatocellular..:
Yavuz, Betul Gok
;
Pestana, Roberto Carmagnani
;
Abugabal, Yehia I.
...
Oncotarget. 11 (2020) 13 - p. 1186-1201 , 2020
Link:
https://doi.org/10.18632..
?
10
Individual ingredients of NP-101 (Thymoquinone formula) inh..:
Maen, Abdelrahim
;
Gök Yavuz, Betül
;
Mohamed, Yehia I
...
Frontiers in Pharmacology. , 2024
Link:
https://hdl.handle.net/2..
?
11
Serum IGF-1 Scores and Clinical Outcomes in the Phase III I..:
Kaseb, Ahmed O
;
Guan, Yinghui
;
Gok Yavuz, Betul
...
info:eu-repo/semantics/altIdentifier/doi/10.2147/JHC.S369951. , 2022
Link:
https://www.dovepress.co..
?
12
Serum IGF-1 Scores and Clinical Outcomes in the Phase III I..:
Kaseb, Ahmed O
;
Guan, Yinghui
;
Gok Yavuz, Betul
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569161/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
13
A Randomized, Double-Blind, Placebo-Controlled, Multicenter..:
Bencheqroun, Hassan
;
Ahmed, Yasir
;
Kocak, Mehmet
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144779/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
14
A randomized, double-blind, placebo-controlled, multicenter..:
Bencheqroun, Hassan
;
Ahmed, Yasir
;
Koçak, Mehmet
...
Pathogens. , 2022
Link:
https://hdl.handle.net/2..
?
15
A randomized, double-blind, placebo-controlled, multicenter..:
Bencheqroun, Hassan
;
Ahmed, Yasir
;
Koçak, Mehmet
...
Pathogens. , 2022
Link:
https://hdl.handle.net/2..
1-15
